Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by J. W. Coons Advisors LLC

J. W. Coons Advisors LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,497 shares of the medical equipment provider’s stock after purchasing an additional 20 shares during the quarter. J. W. Coons Advisors LLC’s holdings in Intuitive Surgical were worth $741,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of ISRG. Castleark Management LLC increased its position in shares of Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock worth $47,221,000 after acquiring an additional 2,990 shares in the last quarter. Arlington Trust Co LLC increased its position in shares of Intuitive Surgical by 34.5% in the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider’s stock worth $369,000 after acquiring an additional 191 shares in the last quarter. Aaron Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider’s stock worth $1,243,000 after acquiring an additional 78 shares in the last quarter. Ewing Morris & Co. Investment Partners Ltd. purchased a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $454,000. Finally, Whalerock Point Partners LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $209,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on ISRG. Barclays decreased their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. Piper Sandler reduced their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a “hold” rating to a “sell” rating and dropped their price objective for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Finally, Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $593.09.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the business’s stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president owned 907 shares of the company’s stock, valued at $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director directly owned 6,371 shares of the company’s stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock worth $2,611,577 in the last 90 days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Stock Down 1.0%

ISRG stock opened at $511.00 on Wednesday. The firm has a market cap of $183.15 billion, a PE ratio of 74.93, a P/E/G ratio of 5.47 and a beta of 1.64. The business has a 50 day moving average of $535.90 and a 200-day moving average of $536.29. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. Intuitive Surgical’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same period last year, the firm earned $1.78 EPS. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.